Most people who are considering stopping kratom don't bring it up with their doctor. Some have never told anyone. Others aren't sure how their prescriber will respond — whether they'll be judged, lectured, or referred somewhere they don't want to go. Others aren't sure if the conversation is even necessary or useful.
Whether you bring this to your existing prescriber or start fresh with a telehealth clinician specifically for this, the conversation is worth having — especially if you're a heavy user, using extract or 7-OH products, or stopping in a context with other complicating factors. This article gives you the practical framework for having it.
TL;DR: Prescribers increasingly encounter kratom users, but the clinical knowledge is uneven — you may know more about kratom than your doctor does. Being specific about what you've been using (product type, dose, duration) is more useful than general disclosures. The main clinical options you may want to discuss are buprenorphine as a withdrawal bridge, clonidine for symptom management, and hydroxyzine for anxiety. If your existing prescriber isn't a good fit for this conversation, a telehealth MAT clinician is an accessible alternative.
Do you need to talk to a prescriber?
Not everyone stopping kratom needs to involve a clinician. Most leaf-powder users without complicating factors can manage withdrawal at home. A few situations make the clinical conversation worthwhile:
- You're also stopping or reducing benzodiazepines or heavy alcohol use (seizure risk — this one is not optional)
- You've been using kratom extract or 7-OH products at high doses
- You have significant cardiac history or other chronic conditions that complicate the withdrawal period
- You've had multiple attempts that didn't get through the acute phase
- You want access to buprenorphine as a bridge medication
- You have a prescription medication regimen and want to check for interactions
If none of these apply, the conversation is still not harmful — but it's not medically necessary for most leaf-powder users. If any apply, it's worth prioritizing.
What to tell your prescriber: the practical script
Prescribers often know less about kratom than patients who have been researching it for months. Going in with specifics is more useful than a vague disclosure. Here's the information that actually changes the clinical picture:
What you've been using
Product type matters more than you might expect. There's a meaningful difference between:
- Leaf powder (traditional form, primarily mitragynine)
- Kratom extract (concentrated, variable 7-OH content)
- 7-OH-specific products (MIT45 liquid shots, labeled 7-OH products)
Your prescriber may not know this distinction. A brief explanation — "I've been using leaf powder in capsule form, not extracts" or "I've been using MIT45 shots, which are concentrated 7-OH products" — tells them something clinically relevant about the withdrawal intensity and options.
Your dose
Give them a number in grams per day, or the number of capsules/shots if you don't have a gram count. If you're unsure of the exact amount, give a range. "I've been using roughly 10-12 grams of leaf powder a day" or "I've been taking 2-3 MIT45 shots a day" is useful. "A lot" or "more than I should" is not.
How long you've been using
Duration matters for the intensity of dependence and the expected length of the withdrawal and PAWS periods. "About 18 months of daily use" or "approximately 3 years" — an approximation is fine.
What you want from this conversation
Most prescribers appreciate patients who come in with a specific ask rather than an open-ended disclosure that leaves the clinical direction unclear. Possible asks:
- "I'm planning to taper and stop. I want to know if buprenorphine makes sense as a bridge for me, given my use pattern."
- "I'm going to try to stop at home but wanted to flag this in case I need support during the acute phase. Can you prescribe hydroxyzine or clonidine if I need them?"
- "I'm stopping next month and wanted to make sure there are no interactions with my current medications."
- "I've tried to stop three times and the withdrawal has been too intense to manage. I'd like to discuss clinical options."
What to ask about: clinical options
Buprenorphine (Suboxone) as a withdrawal bridge
Buprenorphine is a partial opioid receptor agonist used for opioid use disorder treatment (MAT — medication-assisted treatment). It stabilizes opioid receptor activity, reduces acute withdrawal symptoms significantly, and is the most evidence-supported clinical option for managing opioid-like withdrawal — including, in clinical case series and emerging research, kratom withdrawal.
The conversation to have: "I've been reading that buprenorphine can be used as a short-term bridge for kratom withdrawal. Given my use pattern [describe your situation], does that make sense for me? What would it look like — short-term stabilization, or longer-term maintenance?"
Prescribers who are MAT-experienced will know this option. Prescribers who don't have MAT experience may not. If your existing prescriber doesn't have experience with buprenorphine for opioid-use recovery, a telehealth MAT clinician is the appropriate referral.
Important to know: buprenorphine for kratom withdrawal is typically used as a short-term bridge (weeks to a few months), not indefinite maintenance — though the decision belongs to the prescriber and the patient together based on the specific situation. It is not interchangeable with methadone, which requires a licensed opioid treatment program (OTP) and is typically reserved for more severe opioid use disorder.
Clonidine for symptom management
Clonidine is an alpha-2 adrenergic agonist that suppresses the noradrenergic component of opioid withdrawal — the anxiety, sweating, elevated heart rate, and restlessness that characterize the acute phase. It doesn't address the opioid receptor component directly (it's not an opioid), but it makes the acute phase more manageable by targeting the autonomic symptoms.
It's available via prescription and is used off-label for opioid withdrawal management. If you're not pursuing buprenorphine but want something beyond OTC options for the acute phase, clonidine is worth asking about.
Note: clonidine lowers blood pressure, which means it's not appropriate for everyone. Your prescriber will check this.
Hydroxyzine for anxiety
Hydroxyzine is a prescription antihistamine with anxiolytic (anti-anxiety) properties. It's non-habit-forming and commonly used for withdrawal-related anxiety — including in kratom withdrawal. It doesn't carry the dependence risk of benzodiazepines (which should not be used for kratom withdrawal in most cases — trading one dependence for another with added seizure risk is not a good trade).
Hydroxyzine is available via telehealth and is generally well-tolerated. If the anxiety component of your withdrawal is the part you're most concerned about, asking about hydroxyzine is reasonable.
Checking for medication interactions
If you're on other prescription medications, kratom is metabolized primarily by CYP3A4 and CYP2D6 enzymes — the same cytochrome P450 pathways that metabolize many antidepressants, antihistamines, and other drugs. Stopping kratom changes how these pathways are occupied, which can affect the blood levels of other medications.
This is worth flagging to your prescriber, particularly if you're on SSRIs, SNRIs, or other medications with CYP3A4 or CYP2D6 interactions. It's usually not a major concern for most people, but your prescriber should know you've been using kratom when calibrating other medications.
If your prescriber doesn't know about kratom
It's genuinely common to know more about kratom than your doctor does — particularly if your prescriber hasn't encountered kratom patients before, or works in an area where it's less prevalent. This doesn't mean the conversation isn't worth having, but it does mean you may need to lead it rather than follow.
A brief framing that works: "I've been using kratom — it's a plant-based substance with opioid receptor activity — daily for [duration] and I'm working on stopping. The withdrawal is similar to opioid withdrawal. I want to make sure we're on the same page and I know what options are available if I need them."
You don't need to educate your doctor about kratom's mechanism in detail. You do need to give them enough to work with clinically. The key clinical facts: opioid receptor activity, daily use for [duration], [dose], [product type]. That's what changes the prescription decisions.
If your current prescriber isn't the right fit
Some people find that their existing prescriber isn't a good fit for this conversation — either because of limited kratom knowledge, a judgmental response, or a clinical approach that doesn't match what they're looking for.
The alternatives:
- Telehealth MAT clinicians — prescribers who specialize in medication-assisted treatment for opioid-related conditions. Many see kratom patients. Accessible without a referral. The SAMHSA treatment locator at findtreatment.gov can help identify options, or search "buprenorphine telehealth" to find services.
- Addiction medicine specialists — physicians with specialty training in addiction medicine. May be more familiar with kratom than primary care. Referral typically needed.
- Harm reduction clinics — some community health centers have harm reduction programs that include clinical support for kratom withdrawal without requiring an opioid use disorder diagnosis.
The conversation doesn't have to happen with the person who knows your full medical history. It has to happen with someone who can write a prescription if that's where it goes, and who will approach your situation without judgment.
What most prescribers get wrong about kratom
A few common missteps to watch for in the clinical conversation:
Treating kratom as equivalent to full opioids. Kratom leaf powder's primary alkaloid (mitragynine) is a partial opioid receptor agonist — meaningfully different from full agonists like heroin or oxycodone. A prescriber who treats leaf-powder kratom withdrawal identically to heroin withdrawal may be overestimating what you're dealing with (or recommending treatment intensity you don't need). If you've been using 7-OH extracts, the comparison is more apt — that's worth clarifying.
Dismissing kratom as "just a supplement." The withdrawal is real and has a documented clinical profile. A prescriber who dismisses kratom dependence because kratom "isn't a real drug" is working with incomplete information. Acknowledge the response without argument and, if needed, find a different prescriber.
Offering benzodiazepines for withdrawal anxiety. Benzodiazepines are occasionally offered for opioid withdrawal anxiety. In most kratom withdrawal situations, this isn't the right tool — it substitutes one dependence for another and adds a seizure risk on the back end. Hydroxyzine is the appropriate anxiolytic for most kratom withdrawal situations.
Coach Aria is a 12-week digital coaching program for people in kratom recovery. For people working on kratom recovery with clinical support — whether that's buprenorphine, other prescribed medications, or just a prescriber who knows what's happening — Coach Aria provides the behavioral and support structure that works alongside clinical care. It runs privately on your phone.
This article is informational and not a substitute for clinical advice. The clinical options described should be evaluated by a prescriber based on your individual health situation.